Press Releases Renalytix Plc

Equities

Delayed London S.E. Other stock markets 03:00:08 2024-04-30 am EDT			5-day change	1st Jan Change
22.6 ^GBX	-5.83%		-17.82%	+45.81%

Apr. 18	Renalytix chief business officer to become president	AN
Apr. 18	Renalytix Names Chief Business Officer as President	MT

Pentwater Capital Management LP - Form 8.3 - Renalytix PLC	Apr. 26	PR
Renalytix : Notification letter April 2024	Apr. 03	PU
Form 8.5 (EPT/RI) - Renalytix plc	Apr. 03	AQ
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	Mar. 15	PR
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	Mar. 14	PR
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	Mar. 14	PR
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	Mar. 13	PR
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	Mar. 13	PR
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	Mar. 05	PR
Renalytix : Notification letter November 2023	Nov. 15	PU
Renalytix : Depositary’s Notice of AGM 2023 (For holders of ADSs)	Nov. 15	PU
Renalytix : Proxy Card 2023 (for holders of ADSs)	Nov. 15	PU
Renalytix Reports Full Year Fiscal 2023 Results	23-09-28	AQ
Renalytix : Issue of Shares - Form 8-K	23-07-17	PU
Renalytix : Directorate Change - Form 8-K	23-07-03	PU
Renalytix : Regulation FD Disclosure - Form 8-K	23-07-03	PU
Renalytix : Announces Results of General Meeting - Form 6-K	23-06-09	PU
Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes	23-05-26	AQ
Renalytix : Notice of General Meeting - Form 6-K	23-05-11	PU
Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results	23-03-30	AQ

No results for this search